Sanofi ranks 3rd on the 2012 Access to Medicine Index
December 7, 2012
A third place in recognition of the company’s long-term strategy for improving access to healthcare and its efforts to raise the hopes of patients around the world.
Sanofi is noted for its research efforts in neglected tropical diseases (1), high-incidence infectious diseases (2) in developing countries, and chronic diseases (3), as well as the broad range of molecules in its pipeline. Sanofi is also well positioned for its leadership in public policy, sustainable philanthropy and drug donations through the Sanofi Espoir Foundation, together with its organization and system for managing differentiated prices and its capacity to work with local governments.
As a responsible healthcare company, Sanofi is committed to continuing its efforts to reduce inequalities in access to healthcare, medicines and vaccines.